Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate.
Jiang X, Forrest D, Nicolini F, Turhan A, Guilhot J, Yip C, Holyoake T, Jorgensen H, Lambie K, Saw KM, Pang E, Vukovic R, Lehn P, Ringrose A, Yu M, Brinkman RR, Smith C, Eaves A, Eaves C.
Jiang X, et al. Among authors: eaves a, eaves c.
Blood. 2010 Sep 23;116(12):2112-21. doi: 10.1182/blood-2009-05-222471. Epub 2010 Jun 23.
Blood. 2010.
PMID: 20574046
Free PMC article.